Discounted Cash Flow
Biontech SE ADR
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2017 | $61.6m | $-85.7m | $-63.1m | -139.1% | $-0.51 |
| 2018 | $127.6m (107.1%) | $-48.0m (43.9%) | $-80.9m (-28.2%) | -37.6% (72.9%) | $-0.25 (51.0%) |
| 2019 | $108.6m (-14.9%) | $-179.1m (-272.9%) | $-232.4m (-187.4%) | -164.9% (-338.1%) | $-0.85 (-240.0%) |
| 2020 | $482.3m (344.2%) | $15.2m (108.5%) | $-52.2m (77.5%) | 3.2% (101.9%) | $0.06 (107.1%) |
| 2021 | $19.0b (3834.4%) | $10.3b (67622.7%) | $814.5m (1659.8%) | 54.2% (1621.3%) | $42.18 (70200.0%) |
| 2022 | $17.3b (-8.8%) | $9.4b (-8.3%) | $13.5b (1551.8%) | 54.5% (0.5%) | $38.78 (-8.1%) |
| 2023 | $3.8b (-77.9%) | $930.3m (-90.1%) | $5.2b (-61.4%) | 24.4% (-55.3%) | $3.87 (-90.0%) |
| 2024 | $2.8b (-28.0%) | $-665.3m (-171.5%) | $-90.3m (-101.7%) | -24.2% (-199.3%) | $-2.77 (-171.6%) |
| 2025 | $2.9b (4.3%) | $-1.1b (-70.8%) | $73.2m (181.1%) | -39.6% (-63.7%) | $-4.70 (-69.7%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Values abbreviated: b = billions, m = millions, k = thousands.
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.